Tri Locum Partners LP Quant / Systematic

Location: New York, NY

CIK: 0001826434 · Show all filings

Period: Q2 2021 (← Previous) (Next →)

Filing Date: Aug 16, 2021

Total Value: $306M (100.0% shares, 0.0% debt)

Holdings (29)

WALGREENS BOOTS ALLIANCE INC 17.2%
Value $52.61M Shares 1,000,000 Est. Cost $40.65 Unrealized
REGN REGENERON PHARMACEUTICALS 13.8%
Value $42.24M Shares 75,627 Est. Cost $494.28 Unrealized +1.9%
HORIZON THERAPEUTICS PUB L 7.9%
Value $24.14M Shares 257,764 Est. Cost $92.04 Unrealized
MDT MEDTRONIC PLC 7.5%
Value $22.92M Shares 184,680 Est. Cost $96.06 Unrealized +14.0%
WALGREENS BOOTS ALLIANCE INC 7.3%
Value $22.39M Shares 425,671 Est. Cost $40.65 Unrealized
JAZZ JAZZ PHARMACEUTICALS PLC 5.2%
Value $15.88M Shares 89,370 Est. Cost $164.55 Unrealized +5.3%
PTGX PROTAGONIST THERAPEUTICS INC 5.0%
Value $15.33M Shares 341,650 Est. Cost $24.37 Unrealized +35.5%
JNJ JOHNSON & JOHNSON 4.6%
Value $14.1M Shares 85,596 Est. Cost $128.00 Unrealized +13.2%
CI CIGNA CORP NEW 3.9%
Value $12.02M Shares 50,699 Est. Cost $229.72 Unrealized 0.0%
ALDX ALDEYRA THERAPEUTICS INC 3.0%
Value $9.268M Shares 818,025 Est. Cost $12.02 Unrealized 0.0%
PFE PFIZER INC 2.6%
Value $7.937M Shares 202,692 Est. Cost $30.99 Unrealized 0.0%
EOLS EVOLUS INC 2.1%
Value $6.285M Shares 496,826 Est. Cost $10.71 Unrealized +2.7%
INTRA CELLULAR THERAPIES INC 2.0%
Value $6.155M Shares 150,783 Est. Cost $40.82 Unrealized
CLDX CELLDEX THERAPEUTICS INC NEW 1.9%
Value $5.862M Shares 175,305 Est. Cost $22.96 Unrealized +19.5%
HUM HUMANA INC 1.6%
Value $5.005M Shares 11,305 Est. Cost $381.33 Unrealized +9.6%
EW EDWARDS LIFESCIENCES CORP 1.6%
Value $4.999M Shares 48,267 Est. Cost $94.26 Unrealized 0.0%
ENDO INTL PLC 1.6%
Value $4.905M Shares 1,048,100 Est. Cost Unrealized
FLGT FULGENT GENETICS INC 1.5%
Value $4.612M Shares 50,000 Est. Cost Unrealized
MRNA MODERNA INC 1.5%
Value $4.51M Shares 19,193 Est. Cost $178.71 Unrealized 0.0%
TEVA TEVA PHARMACEUTICAL INDS LTD 1.4%
Value $4.414M Shares 445,900 Est. Cost Unrealized
EGRX EAGLE PHARMACEUTICALS INC 1.3%
Value $4.063M Shares 94,922 Est. Cost $41.26 Unrealized 0.0%
MREO MEREO BIOPHARMA GROUP PLC 1.3%
Value $3.974M Shares 1,253,729 Est. Cost $3.17 Unrealized
LIFESCI ACQUISITION II CORP 0.9%
Value $2.699M Shares 269,872 Est. Cost $10.67 Unrealized
AVADEL PHARMACEUTICALS PLC 0.7%
Value $2.112M Shares 313,795 Est. Cost $7.91 Unrealized
ARGX ARGENX SE 0.6%
Value $1.929M Shares 6,408 Est. Cost $301.03 Unrealized
CYCLACEL PHARMACEUTICALS INC 0.6%
Value $1.855M Shares 313,331 Est. Cost $7.03 Unrealized
FEMY FEMASYS INC 0.5%
Value $1.531M Shares 188,753 Est. Cost $9.55 Unrealized 0.0%
BELLUS HEALTH INC NEW 0.4%
Value $1.168M Shares 375,520 Est. Cost $3.84 Unrealized
IVERIC BIO INC 0.2%
Value $611K Shares 96,820 Est. Cost $6.31 Unrealized